Our gut bacteria can play a role in everything from sleep to IBS and how we deal with stress, and we are finally working out how to use them to improve our health.
In the last 10 years, interest in the microbiome – the vast colonies of bacteria and other organisms living in our digestive system – has intensified, including its possible role in gut complaints such as irritable bowel syndrome. Studies have shown that the faecal microbiota of people with IBS differs significantly from those of people who don’t have it. Some suggest that a course of antibiotics raises the risk of developing a functional gut disorder like IBS – another hint that an imbalance in gut bacteria might be involved.
4D Pharma plc (LON:DDDD) is a world leader in the development of live biotherapeutics, a novel and emerging class of drugs, defined by the FDA as biological products that contain a live organism, such as a bacteria, that is applicable to the prevention, treatment or cure of a disease.
